MedTrace Logo

Efficacy Comparison Between Different Management Strategies for Consistent OAB in Patients With SVMs After Surgery

NCT03280316 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2020-04-29

No results posted yet for this study

Summary

The investigators' goal is to compare the efficacy of three different management strategies (sacral neuromodulation, botulinum toxin, M receptor antagonist) in treating consistent OAB in patients with SVMs after surgery.

Conditions

Interventions

PROCEDURE

surgery

patients with SVMs receive surgery

PROCEDURE

sacral neuromodulation

sacral neuromodulation (SNM) with InterStimTM

PROCEDURE

botulinum toxin A injection

BOTOX

DRUG

M receptor antagonist

Tolterodine

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    lead OTHER

Principal Investigators

  • tongwen ou, M.D · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2023-10-31
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03280316 on ClinicalTrials.gov